-
effectivehealthcare.ahrq.gov/health-topics/immune-system-and-disorders
July 16, 2013 - Protocol
October 11, 2016
The Effectiveness of Disease-Modifying Antirheumatic Drugs … – An Update
Research Protocol
May 24, 2017
Disease-Modifying Antirheumatic Drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_overview.pdf
March 27, 2014 - Disease-Modifying Antirheumatic Drugs … Document
Results of Topic Selection Process & Next Steps
§ The topic, Disease-Modifying Antirheumatic Drugs … Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic Arthritis
(JIA). … update surveillance of Comparative Effectiveness Review (CER) #28: Disease-Modifying
Antirheumatic Drugs
-
effectivehealthcare.ahrq.gov/health-topics/health-literacy
September 30, 2009 - Protocol
Archived
December 6, 2011
Communicating Harms and Benefits of Prescription Drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/kravitz_eccs2012.pdf
January 01, 2012 - Slide 6: Direct-‐to-‐Consumer Advertising
of Prescription Drugs … Products
Patients Remembered
Seeing Advertised
Percentage of
Patients Who
Requested
Advertised Drugs … condemnation cycle
Slide 11: Evaluating
the Accuracy and Balance of Media Reports
on
Prescription Drugs … Journalists
are
now in a difficult position with
regard
to
reporting on
prescription
drugs … • HealthNewsReview.org gives expert, independent review of media reports
on prescription drugs and
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicare-medication-use_research.pdf
April 01, 2014 - Care
for chronic physical and psychiatric conditions often includes the
use of multiple prescription drugs … Medicare
Part D program between 2005 and 2006, Medicare expenditures
for outpatient prescription drugs … Drugs are consolidated into 95
drug groups, and drug groups are
consolidated into 18 drug categories … Antipsychotic use: We considered
beneficiaries to be using antipsychotic or
antimanic drugs if they … Neuromuscular drugs Anticonvulsants
Cardiovascular agents Diuretics Neuromuscular drugs Antimyasthenic
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1512.pdf
December 01, 2015 - Boston (MA): Vertex Pharmaceuticals, Inc.; 2014
Nov 05 [accessed 2014 Dec 11]. [3 p]. … Boston (MA): Vertex Pharmaceuticals
Incorporated [accessed 2015 Dec 10]. [2 p]. … MannKind Corporation, Takeda Pharmaceuticals
America, Inc, Genentech USA, Inc. … Boehringer Ingelheim Pharmaceuticals, Inc. … Ridgefield
(CT): Boehringer Ingelheim Pharmaceuticals, Inc.;
2014 Oct. 18 p.
-
effectivehealthcare.ahrq.gov/products/dietary-supplements/
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1406.pdf
June 01, 2014 - Given the limited pharmacologic treatment options for obesity,
additional pharmaceuticals intended … San Diego (CA): Arena
Pharmaceuticals, Inc; 2010 Nov 09 [accessed
2011 Dec 16]. [3 p]. … Washington (DC): Arena
Pharmaceuticals, Inc.; 2009 Oct 27 [accessed
2011 Apr 21]. [4 p]. … San
Diego (CA): Arena Pharmaceuticals, Inc.; 2010
Jul 01 [accessed 2014 Apr 29]. [3 p]. … San Diego (CA): Arena
Pharmaceuticals; 2012 Jun 27 [accessed 2012
Jul 05]. [4 p].
-
effectivehealthcare.ahrq.gov/products/diabetes-oral-medicines-nephropathy/research
January 01, 2005 - Comparative effectiveness research using electronic health records: impacts of oral antidiabetic drugs
-
effectivehealthcare.ahrq.gov/products/antipsychotic-medicine-cardiovascular-elderly/research
March 18, 2009 - 10 Another observational study found higher mortality in those given haloperidol vs. two atypical drugs … FDA warns antipsychotic drugs may be risky for elderly. JAMA 2005;293:2462.
3. Strong C. … Using antipsychotic agents in older patients: expert consensus panel for using antipsychotic drugs in … Antipsychotic drugs: prolonged QTc Interval, Torsade de Pointes, and sudden death. … Antipsychotic drugs in dementia: what should be made of the risks? JAMA 2005;294:1963-1965.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-off-label-update_research-protocol.pdf
May 19, 2010 - These drugs have been studied for
off-label use in several conditions. … published studies on
atypical antipsychotics and found that the most common off-label uses of the drugs … treatment for agitation in dementia, association between the increased risk of death
and antipsychotics drugs … Sub-Question 2: How do atypical antipsychotic medications compare with other
drugs, including first … How do they compare within the class and with other
drugs used for the conditions?
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1306.pdf
July 01, 2013 - San Diego (CA): Arena
Pharmaceuticals, Inc; 2010 Nov 9 [accessed 2011
Dec 16]. [3 p]. … Washington (DC): Arena
Pharmaceuticals, Inc.; 2009 Oct 27 [accessed
2011 Apr 21]. [4 p]. … San Diego (CA): Arena
Pharmaceuticals, Inc.; 2009 Dec 22 [accessed
2012 Mar 26]. [2 p]. … San Diego (CA): Arena
Pharmaceuticals; 2012 Jun 27 [accessed 2012
Jul 5]. [4 p]. … Arena Pharmaceuticals. Lorcaserin
hydrochloride. Drugs Future. 2007;32(9):766-70.
77.
-
effectivehealthcare.ahrq.gov/sites/default/files/06_devdelays_autism_potential_high_impact_june_2012.pdf
January 01, 2012 - Coordinating Council for Comparative Effectiveness
Research, AHRQ is interested in innovations in drugs … In the health care sector, horizon
scanning pertains to identifying new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices,
procedures … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the … These drugs will likely face intense scrutiny, considering the
challenges of accurately diagnosing
-
effectivehealthcare.ahrq.gov/products/medicare-medication-use/research
April 23, 2014 - Care for chronic physical and psychiatric conditions often includes the use of multiple prescription drugs … Multiple medications and use of psychotropic drugs increases the possibility of adverse drug events. … the Medicare Part D program between 2005 and 2006, Medicare expenditures for outpatient prescription drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-reporting-bias_methods.pdf
November 01, 2013 - Regulatory Documents
Reviews of Drugs Compared With Devices
Drugs and devices are both regulated by … • Reviewers should search Drugs@FDA for information on drugs; if a search is not
conducted reviewers … However, the Web site typically does not have
documents related to older drugs and very new drugs. … International Conference on Harmonisation of
Technical Requirements for Registration of
Pharmaceuticals … For
drugs: generic name, or temporary identifier for drugs that do not yet have a generic name;
for
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1412.pdf
October 01, 2015 - Cambridge (MA): Vertex
Pharmaceuticals, Inc.; 2011 Nov 03 [accessed 2014
Apr 10]. [4 p]. … Cambridge (MA): Vertex
Pharmaceuticals, Inc.; 2010 Nov 08 [accessed 2011
Jan 04]. [1 p]. … Boston (MA): Vertex Pharmaceuticals, Inc.; 2014
Nov 05 [accessed 2014 Dec 11]. [3 p]. … Boehringer Ingelheim Pharmaceuticals, Inc. … Ridgefield (CT):
Boehringer Ingelheim Pharmaceuticals, Inc.; 2014
Oct. 18 p.
-
effectivehealthcare.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_2012-12-11.pdf
January 01, 2012 - Coordinating Council for Comparative Effectiveness
Research, AHRQ is interested in innovations in drugs … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices,
procedures … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the … Vertex Pharmaceuticals Incorporated. … Vertex Pharmaceuticals Incorporated.
-
effectivehealthcare.ahrq.gov/products/safety-emerging-methods/executive
September 25, 2007 - Assessment of Adherence to and Persistence on Disease-Modifying Antirheumatic Drugs (DMARDs) in Patients … Assessment of Adherence to and Persistence on Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Patients … Comparison of Meta-Analytic Results of Indirect, Direct, and Combined Comparisons of Drugs for Chronic … Comparison of Meta-Analytic Results of Indirect, Direct, and Combined Comparisons of Drugs for Chronic
-
effectivehealthcare.ahrq.gov/sites/default/files/04_dementia_potential_high_impact_june_2012.pdf
January 01, 2012 - In the health care sector, horizon
scanning pertains to identifying new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices,
procedures … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the … The search is on for ways to definitively diagnose AD and for drugs, biologics, and alternative
or … Peripheral and Central Nervous System Drugs
Advisory Committee.
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-patients-with-crohns-disease-what-treatments-or-therapies-alone-or-in-conjunction-with-one-another-provide-the-highest-rate-of-disease-management-with-the-lowest-risk-of-long-term-complications-particularly-in-young-women
March 10, 2009 - yes
If yes, explain the specific technologies, devices, drugs, or interventions you would like to … Any additional evidence will provide peace of mind as well as potential financial relief since the drugs … Any additional evidence will provide peace of mind as well as potential financial relief since the drugs